Cancer Stem Cells: Future anti-cancer drug therapy
Market Overview According to a new report published by Reports Monitor titled, “Cancer Stem Cells Market by Mode of Action, and Cancer Type: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the cancer stem cells market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025.
There has growing evidences in recent past few years that cancer stem cells are critical in the formation of tumours. Scientist has revealed that cancer cells not only can self renew by diving bust also can generate all other cell types found in the tumour. CSCs are perceived to be an important target for novel anti-cancer drug discovery. The clinical importance of cancer stem cells has been consolidated by emerging affirmation, demonstrating that CSCs are combative to traditional radiation and chemotherapy treatment and that CSCs are tend to be the root of cancer metastasis.
As cancer stem cell have substantial potential of treating cancer effectively and already has been tested on laboratory animal models showing satisfactory results the market for CSCs is blooming. Increasing rate of cancer mortality and morbidity worldwide, need for cancer preventive solution & treatment, surging R&D activities by government bodies and private research organizations drives the growth of the market. Additionally, increased funding, well-established research infrastructure, development in technology and increased awareness flourishes the market expansion. However, social & ethical issues regarding human testing of cancer stem cells, production complications, development & implementation of cell therapy and genetic instability are some of the aspects that may roadblock the market growth.
Growth of cancer stem cell market in Asia-Pacific is consolidated by constantly performed R&D programs & clinical trials, various pharmaceutical & biotechnological companies as well as government largely investing for deep research and development in technology. The global cancer stem cell market is segmented on the basis of mode of action, cancer types and region. Based on mode of action the cancer stem cells market is segmented into targeted cancerous stem cells and stem cells based cancer therapy. Targeted cancerous stem cells further distributed into pathway inhibitors, surface marker-based, immune-evasion & targeting tumour microenvironment, nanoparticle-based therapies and others. Stem cell-based cancer therapy is spilt into autologous stem cell transplant and allogeneic stem cell transplant. Depending upon cancer types the market is bifurcated into breast cancer, pancreas caner, lung cancer, blood cancer, colorectal cancer, liver cancer, bladder cancer, brain cancer and others.
Competitive Analysis Major players operating in the market include STEMCELL Technologies Inc., Advanced Cell Diagnostics, Fluxion Biosciences, Inc., Thermo Fisher Scientific, Inc., Bionomics, PromoCell GmbH, Silicon Biosystems, S.p.A., Rarecells USA, Inc., AbbVie, Inc. and Irvine Scientific. Agreements and collaborations, acquisitions, clinical trials and new product launches, product pipelines are few of the game plans adopted by the players to maintain and sustain their position in the market.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.